GUIDED THERAPEUTICS INC Quarterly Nonoperating Income (Expense) in USD from Q2 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Guided Therapeutics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2022 to Q2 2024.
  • Guided Therapeutics Inc Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$54K, a 3.85% decline year-over-year.
  • Guided Therapeutics Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$51K.
  • Guided Therapeutics Inc annual Nonoperating Income (Expense) for 2023 was -$32K, a 96.8% increase from 2022.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$51K -$54K -$2K -3.85% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$49K -$43K -$17K -65.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$32K $100K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$54K -$176K -144% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$52K +$157K +75.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$26K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $122K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$209K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.